Advanced in Neuroblastoma

Kyung-nam N. Koh

Olympic Road 43 Road 88, 
Seoul, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Neuroblastoma
Olympic Road 43 Road 88, 
Seoul, KR 
OverviewLocationsClinical Research

Overview

Kyung-nam Koh practices in Seoul, Republic of Korea. Koh is rated as an Advanced expert by MediFind in the treatment of Neuroblastoma. Their top areas of expertise are Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hepatoblastoma, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 92 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Neuroblastoma.

Locations

Olympic Road 43 Road 88, Seoul, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
Enrollment Status: Recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Drug: Oral Repotrectinib (TPX-0005)
Study Phase: Phase 1/Phase 2
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2024
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

92 Total Publications

Upfront Haploidentical Hematopoietic Cell Transplantation Using αβ+ T Cell-Depleted Peripheral Blood Stem Cells for Pediatric Patients with Acquired Severe Aplastic Anemia.
Upfront Haploidentical Hematopoietic Cell Transplantation Using αβ+ T Cell-Depleted Peripheral Blood Stem Cells for Pediatric Patients with Acquired Severe Aplastic Anemia.
Journal: Transplantation and cellular therapy
Published: March 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Koh's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 40 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile